AT235505T - Oleate monoester of estrogenic for treatment of obesity - Google Patents

Oleate monoester of estrogenic for treatment of obesity

Info

Publication number
AT235505T
AT235505T AT96500140T AT96500140T AT235505T AT 235505 T AT235505 T AT 235505T AT 96500140 T AT96500140 T AT 96500140T AT 96500140 T AT96500140 T AT 96500140T AT 235505 T AT235505 T AT 235505T
Authority
AT
Austria
Prior art keywords
estrogenic
obesity
treatment
oleate monoester
monoester
Prior art date
Application number
AT96500140T
Other languages
German (de)
Inventor
Maria Alemany
Original Assignee
Oleoyl Estrone Developments S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES9502101 priority Critical
Application filed by Oleoyl Estrone Developments S filed Critical Oleoyl Estrone Developments S
Publication of AT235505T publication Critical patent/AT235505T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/28Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with dihydroxylic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/58Esters of straight chain acids with eighteen carbon atoms in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
AT96500140T 1995-10-30 1996-10-28 Oleate monoester of estrogenic for treatment of obesity AT235505T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9502101 1995-10-30

Publications (1)

Publication Number Publication Date
AT235505T true AT235505T (en) 2003-04-15

Family

ID=8291993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96500140T AT235505T (en) 1995-10-30 1996-10-28 Oleate monoester of estrogenic for treatment of obesity

Country Status (7)

Country Link
US (1) US5798348A (en)
EP (1) EP0771817B1 (en)
AT (1) AT235505T (en)
DE (2) DE69626927D1 (en)
DK (1) DK0771817T3 (en)
ES (1) ES2192221T3 (en)
PT (1) PT771817E (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
WO1999066915A2 (en) * 1998-06-23 1999-12-29 Southern Illinois University At Carbondale Therapeutic applications of estrogenic carboxylic acids
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
AU3579200A (en) * 1999-02-26 2000-09-14 Saltech I Goteborg Ab Method and composition for the regulation of hepatic and extrahepatic productionof insulin-like growth factor-1
EP1228083A2 (en) 1999-09-30 2002-08-07 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
US7025984B1 (en) 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
AU2005242170B2 (en) * 2000-06-26 2008-12-18 The Procter & Gamble Company Compositions and methods for body weight management
ES2173049B1 (en) * 2001-03-28 2004-01-16 Oleoyl Estrone Developments S Fatty acid monoester and estrogen as antidiabetic and hypolipidaemic agent.
US6635015B2 (en) 2001-04-20 2003-10-21 The Procter & Gamble Company Body weight management system
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
US20040157816A1 (en) * 2002-08-26 2004-08-12 Girouard Michael P. Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents
WO2003018529A1 (en) * 2001-08-24 2003-03-06 Girouard Michael P Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents
ES2186576B1 (en) * 2001-10-11 2004-09-16 Universitat De Les Illes Balears 2-hydroxyoleic acid for use as a medicament.
AU2003294489A1 (en) * 2002-11-20 2004-06-15 Michael P. Girouard Combination of monounsaturated fatty acids and estrogen, and their use
EP1594439A2 (en) 2003-02-13 2005-11-16 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20070014719A1 (en) 2004-09-29 2007-01-18 Reading Christopher L Steroid analogs and characterization and treatment methods
US20060084637A1 (en) * 2004-10-18 2006-04-20 Maria Alemany Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
US20060084636A1 (en) * 2004-10-18 2006-04-20 Maria Alemany Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US7528791B2 (en) * 2005-08-08 2009-05-05 Wistron Neweb Corporation Antenna structure having a feed element formed on an opposite surface of a substrate from a ground portion and a radiating element
MX2008014870A (en) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Two-piece, internal-channel osmotic delivery system flow modulator.
WO2008147373A2 (en) * 2006-06-26 2008-12-04 Manhattan Pharmaceuticals, Inc. Methods and compositions for reducing body weight using an estrogen fatty ester in an oil
ES2302449B1 (en) * 2006-10-30 2009-06-12 Oleoyl-Estrone Developments, S.L. Monoesters of strogens with conjugated linoleic acid and uses of the same.
CN104000779A (en) 2007-04-23 2014-08-27 精达制药公司 Suspension formulations of insulinotropic peptides and uses thereof
EP2085089A1 (en) * 2008-02-01 2009-08-05 KTB-Tumorforschungs GmbH Phospholipids Containing omega-3-Fatty Acids for the Treatment of Overweight, Obesity and Addictive Behavior
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
CN104323981B (en) 2009-09-28 2019-03-12 精达制药公司 The quick foundation and/or termination of basic steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US20140378424A1 (en) * 2011-12-30 2014-12-25 Rosscreening, Inc. Estrogen receptor modulators for reducing body weight
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2265976A (en) * 1937-10-25 1941-12-09 Schering Corp Tertiary alcohols of the estrane series and their derivatives and a process for their manufacture
GB531178A (en) * 1938-07-02 1940-12-31 Chem Ind Basel Manufacture of new esters of the oxy-stilbene series
JPH0610127B2 (en) * 1985-02-09 1994-02-09 ライオン株式会社 Hair tonic
US4617298A (en) * 1985-10-22 1986-10-14 University Of Florida Method and compositions for weight control

Also Published As

Publication number Publication date
DK0771817T3 (en) 2003-07-28
EP0771817A3 (en) 1999-04-14
EP0771817A2 (en) 1997-05-07
ES2192221T3 (en) 2003-10-01
DE69626927D1 (en) 2003-04-30
EP0771817B1 (en) 2003-03-26
DE69626927T2 (en) 2003-11-20
PT771817E (en) 2003-06-30
DK771817T3 (en)
US5798348A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
DE69617047D1 (en) An arrangement for treatment of the skin
DE69518154D1 (en) Treatment of diabetes
DE69612649D1 (en) Indolinone compounds to treat disease
DE69510427D1 (en) Plasma reactors for wafer treatment
DE69516687T2 (en) Liquid composition for treatment of tissue-paper
DE69627243D1 (en) Device for thermal treatment endovascular
DE69703744D1 (en) A device for treatment of hydrocephalus
AT259812T (en) Novel substituted pyrazole derivatives for the treatment of cardiovascular diseases
AT168007T (en) For treatment of diseases of the central nervous system usable benzimidazole
NO992183L (en) FremgangsmÕte for improved stimulation treatment
RU97120708A (en) Apparatus for thermal treatment of tissue
DE69022249T2 (en) Knochenwachsapplikator for treating bone tissue.
DE69825447D1 (en) Device for dermatological treatment
BR9701562A (en) Treatment of solid effluent containing material derived from
DE69715611T2 (en) Using a rapamycinderivates disease and for treatment of vascular xenotransplantation
DE69909775D1 (en) New fat analog for the treatment of diabetes
DE69533085D1 (en) Apparatus for isolation of vibrating elements medical
DE69532976D1 (en) implantation method of production of tissue for
DE69427830T2 (en) Germs of cobalt-palladium for thermal treatment of tumors
DE69612279D1 (en) Treatment of severe aromatics
DE69721006D1 (en) Use of the modified own blood for the treatment of autoimmune diseases
AT195870T (en) Linsidomin for treatment of erectile dysfunctions
DE69521796D1 (en) Treatment of partial growth hormone insensitivity syndromes
DE69425046T2 (en) A device for treatment of spinal diseases
DE69812681D1 (en) Unsubstituted polydiallylamines for treatment of hypercholesterolemia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0771817

Country of ref document: EP

REN Ceased due to non-payment of the annual fee